Literature DB >> 20429844

Polymeric drug delivery systems for localized cancer chemotherapy.

Raquel De Souza1, Payam Zahedi, Christine J Allen, Micheline Piquette-Miller.   

Abstract

Cancer has become one of the most difficult health challenges of our time, accounting for millions of deaths yearly. Systemic chemotherapy is the most common therapeutic approach; however, considerable limitations exist including toxicities to healthy tissues and low achievable drug concentrations at tumor sites. More than 85% of human cancers are solid tumors, which can greatly benefit from localized delivery. This approach allows for high drug concentrations at the target site, lower systemic toxicity, and extended drug exposure which may be beneficial for cell cycle-specific drugs. Polymers have been widely considered in the development of localized delivery systems. This review focuses on both natural and synthetic biodegradable polymers that have been explored for localized chemotherapy, exploring their advantages, disadvantages, and clinical potential while citing examples of their use in pre-clinical development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20429844     DOI: 10.3109/10717541003762854

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.419


  37 in total

1.  3D superhydrophobic electrospun meshes as reinforcement materials for sustained local drug delivery against colorectal cancer cells.

Authors:  Stefan T Yohe; Victoria L M Herrera; Yolonda L Colson; Mark W Grinstaff
Journal:  J Control Release       Date:  2012-06-06       Impact factor: 9.776

Review 2.  Multifunctional Electrospun Nanofibers for Enhancing Localized Cancer Treatment.

Authors:  Yike Fu; Xiang Li; Zhaohui Ren; Chuanbin Mao; Gaorong Han
Journal:  Small       Date:  2018-06-27       Impact factor: 13.281

3.  Functionalized hydrophobic poly(glycerol-co-ε-caprolactone) depots for controlled drug release.

Authors:  Jesse B Wolinsky; Stefan T Yohe; Yolonda L Colson; Mark W Grinstaff
Journal:  Biomacromolecules       Date:  2012-02-01       Impact factor: 6.988

4.  Polymeric conjugates for drug delivery.

Authors:  Nate Larson; Hamidreza Ghandehari
Journal:  Chem Mater       Date:  2012-01-04       Impact factor: 9.811

5.  Increasing Distribution of Drugs Released from In Situ Forming PLGA Implants Using Therapeutic Ultrasound.

Authors:  Chawan Manaspon; Christopher Hernandez; Pinunta Nittayacharn; Selva Jeganathan; Norased Nasongkla; Agata A Exner
Journal:  Ann Biomed Eng       Date:  2017-09-19       Impact factor: 3.934

Review 6.  Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers.

Authors:  Jesse B Wolinsky; Yolonda L Colson; Mark W Grinstaff
Journal:  J Control Release       Date:  2011-12-01       Impact factor: 9.776

7.  A Fibrous Localized Drug Delivery Platform with NIR-Triggered and Optically Monitored Drug Release.

Authors:  Heng Liu; Yike Fu; Yangyang Li; Zhaohui Ren; Xiang Li; Gaorong Han; Chuanbin Mao
Journal:  Langmuir       Date:  2016-08-24       Impact factor: 3.882

Review 8.  Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed.

Authors:  Berkley E Gryder; Quaovi H Sodji; Adegboyega K Oyelere
Journal:  Future Med Chem       Date:  2012-03       Impact factor: 3.808

9.  The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes.

Authors:  Paul H Kierstead; Hideaki Okochi; Vincent J Venditto; Tracy C Chuong; Saul Kivimae; Jean M J Fréchet; Francis C Szoka
Journal:  J Control Release       Date:  2015-06-18       Impact factor: 9.776

10.  Intraperitoneal delivery of paclitaxel by poly(ether-anhydride) microspheres effectively suppresses tumor growth in a murine metastatic ovarian cancer model.

Authors:  Ming Yang; Tao Yu; Joseph Wood; Ying-Ying Wang; Benjamin C Tang; Qi Zeng; Brian W Simons; Jie Fu; Chi-Mu Chuang; Samuel K Lai; T-C Wu; Chien-Fu Hung; Justin Hanes
Journal:  Drug Deliv Transl Res       Date:  2014-04-01       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.